Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Rudick

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?Richard Rudick
Multiple Sclerosis and Related Disorders|January 27, 2026
Timothy K. Vartanian (1959-2025) pioneering neuroscientist who traced multiple sclerosis to a microbial sourceYinghua Ma, Richard Rudick
Neurology|August 15, 2002
Disease modifying therapies in multiple sclerosisRobert J Fox, Elizabeth Fisher, Richard Rudick
Neurology|April 10, 2002
Lawrence D. Jacobs, MD (1938-2001)Richard Rudick, Bianca Weinstock-Guttman, Frederick Munschauer
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 28, 2017
Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter LesionsYufan Zheng, Jar-Chi Lee, Richard Rudick, et al.
The New England Journal of Medicine|January 18, 2002
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosisAnsi Chang, Wallace W Tourtellotte, Richard Rudick, et al.
JAMA Neurology|November 7, 2012
Natalizumab: bench to bedside and beyondRichard Rudick, Chris Polman, David Clifford, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Cognitive impairment in multiple sclerosis: An 18 year follow-up studyLauren B Strober, Stephen M Rao, Jar-Chi Lee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosisRalph Hb Benedict, John DeLuca, Glenn Phillips, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosisRobert W Motl, Jeffrey A Cohen, Ralph Benedict, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?Richard Rudick
Multiple Sclerosis and Related Disorders|January 27, 2026
Timothy K. Vartanian (1959-2025) pioneering neuroscientist who traced multiple sclerosis to a microbial sourceYinghua Ma, Richard Rudick
Neurology|August 15, 2002
Disease modifying therapies in multiple sclerosisRobert J Fox, Elizabeth Fisher, Richard Rudick
Neurology|April 10, 2002
Lawrence D. Jacobs, MD (1938-2001)Richard Rudick, Bianca Weinstock-Guttman, Frederick Munschauer
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 28, 2017
Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter LesionsYufan Zheng, Jar-Chi Lee, Richard Rudick, et al.
The New England Journal of Medicine|January 18, 2002
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosisAnsi Chang, Wallace W Tourtellotte, Richard Rudick, et al.
JAMA Neurology|November 7, 2012
Natalizumab: bench to bedside and beyondRichard Rudick, Chris Polman, David Clifford, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Cognitive impairment in multiple sclerosis: An 18 year follow-up studyLauren B Strober, Stephen M Rao, Jar-Chi Lee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosisRalph Hb Benedict, John DeLuca, Glenn Phillips, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosisRobert W Motl, Jeffrey A Cohen, Ralph Benedict, et al.
Pageof 3